Chronic inflammation promoted by monocyte/macrophage dysregulation has been correlated with HF progression and poor outcome and its suppression with mineralocorticoid receptor (MR) antagonistsretard the progression and mortality in HF patients [34, 35]. The gene discussed is NR3C2; the disease is hydrops fetalis.